BioSig Technologies Inc. (NASDAQ: BSGM) stock jumped 3.08% on Thursday to $1.50 against a previous-day closing price of $1.46. With 0.7 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.31 million shares. During the session, the Medical Devices company that operates in wider Healthcare sector, reached to the highest price of $1.6500 whereas the lowest price it dropped to was $1.4500. The 52-week range on BSGM shows that it touched its highest point at $1.58 and its lowest point at $0.25 during that stretch. It currently has a 1-year price target of $4.42. Beta for the stock currently stands at 1.38.
Top 5 EV Tech Stocks to Buy for 2023
According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.
Click Here to Download the FREE Report.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of BSGM was up-trending over the past week, with a rise of 1.01%, but this was up by 22.36% over a month. Three-month performance surged to 26.47% while six-month performance rose 280.05%. The stock gained 32.09% in the past year, while it has gained 258.33% so far this year. A look at the trailing 12-month EPS for BSGM yields -0.55 with Next year EPS estimates of -0.33. For the next quarter, that number is -0.10. This implies an EPS growth rate of 32.90% for this year and 15.80% for next year.
Float and Shares Shorts:
At present, 61.43 million BSGM shares are outstanding with a float of 39.04 million shares on hand for trading. On Apr 27, 2023, short shares totaled 1.92 million, which was 2.84% higher than short shares on Mar 30, 2023. In addition to Mr. Kenneth L. Londoner M.B.A., MBA as the firm’s Founder, CEO & Exec. Chairman, Mr. John Sieckhaus serves as its Chief Operating Officer.
Through their ownership of 8.06% of BSGM’s outstanding shares, institutional investors have minority control over the company. Other institutions hold 3.72% of BSGM, in contrast to 3.00% held by mutual funds. Shares owned by individuals account for 12.49%. As the largest shareholder in BSGM with 2.11% of the stake, The Vanguard Group, Inc. holds 1,409,958 shares worth 1,409,958. A second-largest stockholder of BSGM, Advisor Resource Council LLC, holds 924,182 shares, controlling over 1.38% of the firm’s shares. BlackRock Fund Advisors is the third largest shareholder in BSGM, holding 449,021 shares or 0.67% stake. With a 1.46% stake in BSGM, the Vanguard Total Stock Market ETF is the largest stakeholder. A total of 977,203 shares are owned by the mutual fund manager. The Vanguard Extended Market Index Fu, which owns about 0.75% of BSGM stock, is the second-largest Mutual Fund holder. It holds 499,339 shares valued at 0.61 million. Incrementum All Seasons Fund holds 0.24% of the stake in BSGM, owning 158,654 shares worth 0.2 million.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on Mar 30, 2023, BSGM reported revenue of $8.00k and operating income of -$5.72M. The EBITDA in the recently reported quarter was -$5.64M and diluted EPS was -$0.15.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for BSGM since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With BSGM analysts setting a high price target of $5.25 and a low target of $2.00, the average target price over the next 12 months is $3.63. Based on these targets, BSGM could surge 250.0% to reach the target high and rise by 33.33% to reach the target low. Reaching the average price target will result in a growth of 142.0% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy.
Summary of Insider Activity:
Insiders traded BSGM stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has increased to 30 while that of sell transactions has remained unmoved to 0 over the past year. The total number of shares bought during that period was 665,831 while 0 shares were sold.